AI in healthcare is entering a new era of accountability

Pieces Technologies, founded by Dr. Ruben Amarasingham, initially aimed to alleviate clinical workloads using AI, focusing on understanding and assisting clinician workflows. The company faced scrutiny from a Texas Attorney General's investigation into its AI systems' accuracy and safety. This led Pieces to re-evaluate its models, documentation, and safeguards. Pieces was subsequently acquired by Smarter Technologies, signaling a shift in the healthcare AI landscape. The acquisition underscores the increasing importance of trustworthiness, explainability, and safety in healthcare AI. The trend towards greater regulatory oversight is reflected in updated guidance from the FDA and FTC. Clinicians prioritize AI that integrates seamlessly into their workflows, offering clarity, validation, and respect for their clinical judgment. Trust in healthcare AI is built through consistent proof, not mere ambition or branding. Regulatory pressure demands systems with reproducible reasoning, documented controls, and safeguards. The future of healthcare AI hinges on companies prioritizing oversight as a design element. Companies must actively address model bias and demonstrate the ability to detect and correct system drift. The evolution of healthcare AI emphasizes the necessity of continuous improvement to ensure good patient outcomes.